Literature DB >> 2721501

Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation.

J A Garcia1, D Harrich, E Soultanakis, F Wu, R Mitsuyasu, R B Gaynor.   

Abstract

The human immunodeficiency virus (HIV) type 1 LTR is regulated at the transcriptional level by both cellular and viral proteins. Using HeLa cell extracts, multiple regions of the HIV LTR were found to serve as binding sites for cellular proteins. An untranslated region binding protein UBP-1 has been purified and fractions containing this protein bind to both the TAR and TATA regions. To investigate the role of cellular proteins binding to both the TATA and TAR regions and their potential interaction with other HIV DNA binding proteins, oligonucleotide-directed mutagenesis of both these regions was performed followed by DNase I footprinting and transient expression assays. In the TATA region, two direct repeats TC/AAGC/AT/AGCTGC surround the TATA sequence. Mutagenesis of both of these direct repeats or of the TATA sequence interrupted binding over the TATA region on the coding strand, but only a mutation of the TATA sequence affected in vivo assays for tat-activation. In addition to TAR serving as the site of binding of cellular proteins, RNA transcribed from TAR is capable of forming a stable stem-loop structure. To determine the relative importance of DNA binding proteins as compared to secondary structure, oligonucleotide-directed mutations in the TAR region were studied. Local mutations that disrupted either the stem or loop structure were defective in gene expression. However, compensatory mutations which restored base pairing in the stem resulted in complete tat-activation. This indicated a significant role for the stem-loop structure in HIV gene expression. To determine the role of TAR binding proteins, mutations were constructed which extensively changed the primary structure of the TAR region, yet left stem base pairing, stem energy and the loop sequence intact. These mutations resulted in decreased protein binding to TAR DNA and defects in tat-activation, and revealed factor binding specifically to the loop DNA sequence. Further mutagenesis which inverted this stem and loop mutation relative to the HIV LTR mRNA start site resulted in even larger decreases in tat-activation. This suggests that multiple determinants, including protein binding, the loop sequence, and RNA or DNA secondary structure, are important in tat-activation and suggests that tat may interact with cellular proteins binding to DNA to increase HIV gene expression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2721501      PMCID: PMC400873          DOI: 10.1002/j.1460-2075.1989.tb03437.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  49 in total

1.  Identification of the human U7 snRNP as one of several factors involved in the 3' end maturation of histone premessenger RNA's.

Authors:  K L Mowry; J A Steitz
Journal:  Science       Date:  1987-12-18       Impact factor: 47.728

2.  Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat.

Authors:  J Hauber; B R Cullen
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen.

Authors:  P J Mitchell; C Wang; R Tjian
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

4.  Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I.

Authors:  M Siekevitz; S F Josephs; M Dukovich; N Peffer; F Wong-Staal; W C Greene
Journal:  Science       Date:  1987-12-11       Impact factor: 47.728

5.  Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.

Authors:  S Y Kao; A F Calman; P A Luciw; B M Peterlin
Journal:  Nature       Date:  1987 Dec 3-9       Impact factor: 49.962

6.  Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events.

Authors:  J Hauber; A Perkins; E P Heimer; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

7.  Phorbol ester enhances human immunodeficiency virus-promoted gene expression and acts on a repeated 10-base-pair functional enhancer element.

Authors:  J D Kaufman; G Valandra; G Roderiquez; G Bushar; C Giri; M A Norcross
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

8.  Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells.

Authors:  G J Nabel; S A Rice; D M Knipe; D Baltimore
Journal:  Science       Date:  1988-03-11       Impact factor: 47.728

9.  Alterations in binding characteristics of the human immunodeficiency virus enhancer factor.

Authors:  F Wu; J Garcia; R Mitsuyasu; R Gaynor
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

10.  Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus.

Authors:  J A Garcia; F K Wu; R Mitsuyasu; R B Gaynor
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

View more
  141 in total

Review 1.  A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.

Authors:  L A Pereira; K Bentley; A Peeters; M J Churchill; N J Deacon
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

2.  Tat is required for efficient HIV-1 reverse transcription.

Authors:  D Harrich; C Ulich; L F García-Martínez; R B Gaynor
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

3.  Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro.

Authors:  C A Bohan; F Kashanchi; B Ensoli; L Buonaguro; K A Boris-Lawrie; J N Brady
Journal:  Gene Expr       Date:  1992

4.  Cloning and chromosomal mapping of a human immunodeficiency virus 1 "TATA" element modulatory factor.

Authors:  J A Garcia; S H Ou; F Wu; A J Lusis; R S Sparkes; R B Gaynor
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

5.  Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator.

Authors:  E P Loret; P Georgel; W C Johnson; P S Ho
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

6.  Probing protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1 by in vivo footprinting.

Authors:  F Demarchi; P D'Agaro; A Falaschi; M Giacca
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

7.  Functional comparison of the basic domains of the Tat proteins of human immunodeficiency virus types 1 and 2 in trans activation.

Authors:  B Elangovan; T Subramanian; G Chinnadurai
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

Review 8.  Transcriptional and posttranscriptional regulation of HIV-1 gene expression.

Authors:  Jonathan Karn; C Martin Stoltzfus
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

9.  Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins.

Authors:  A P Rice; F Carlotti
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

10.  Activity of synthetic tat peptides in human immunodeficiency virus type 1 long terminal repeat-promoted transcription in a cell-free system.

Authors:  J Jeyapaul; M R Reddy; S A Khan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.